A Retrospective Claims Analysis on Rates of Compliance and Discontinuation Among Canadian Multiple Sclerosis Patients Treated with Disease-Modifying Therapies at 6, 12 and 24-Month Periods
Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.1922
https://www.valueinhealthjournal.com/article/S1098-3015(17)32256-8/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1754
First Page :
A719
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)32256-8&doi=10.1016/j.jval.2017.08.1922